@lost
Still thinking about this in-specie question.
PAC is probably in a rather common situation : a group where the sum of the parts is higher than the market cap.
So, it is interesting to see how most of the groups deal with this question.
I think it is quite rare that they use the "in-specie" solution.
My experience is more than companies decide to do a spin-off to let the market decide what's the real value of the interesting asset.
PAC' situation today is quite similar : the listing of GQG should let the market decide what's the value of this asset.
So, if GQG listing go through and the market values it as we expect, I don't see any reason why it would not be reflected at the end in PAC's market cap.
Of course, at this stage, there may be still be a large discount for PAC vs its sum of the parts.
In that case, it would make sense to think about "in specie".
But, now, it looks a bit early to me.
- Forums
- Lounge
- Fund managers
Fund managers, page-78
- There are more pages in this discussion • 1,340 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online